GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 195 days ( 92.77 % )
Last Price $0.141 -5.37 %
High/ Low $0.140 - $0.146 -2.14%
Chg 7 Days -7.24 % $0.152 $0.141
Chg 30 Days -44.71 % $0.255 $0.141
Chg 12 mos -91.40 % $1.64 $0.141
Trend - 3 mos -50.65 % Width: 1,043.49 %
Trend - 12 mos -84.35 % Width: 172.52 %
Pred. range - 3 mos $0.0137 - $0.157 -90.28 % - 11.14 %
Pred. range - 12 mos N/A - $0.0628 -100.00 % - -55.43 %
Short MA avg 3 mos Sell 2022-08-12 - 4 days
Long MA avg 3 mos Sell 2022-07-11 - 28 days
Short/Long MA avg 3 mos Sell 2022-07-14 - 25 days
Short MA avg 12 mos Sell 2022-08-12 - 4 days
Long MA avg 12 mos Sell 2022-01-04 - 156 days
Short/Long MA avg 12 mos Sell 2022-01-05 - 155 days
Pivot Short Sell 2022-08-11 - 5 days
Bollinger Sell 0000-00-00 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials in anterior uveitis for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of th... EYEG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT